Biomax, Pierre Fabre Collaborate
News Jun 19, 2015
Using the BioXM Knowledge Management Environment, Biomax created the antibody knowledgebase, which offers sequence analysis and storage capabilities, infrastructure for sharing in-house data and algorithms, a collection of public data, and includes both public and third-party algorithms.
Following a successful pilot project, Pierre Fabre has licensed Biomax's BioXM Knowledge Management Environment and agreed to work with the company to further develop and expand the system.
Immatics Enters into a Strategic Partnership with GenmabNews
Immatics and Genmab to combine proprietary technologies to create transformative bispecific therapies against novel, proprietary tumor targets.READ MORE
Antibody Drug May Be Effective Against Broader Class of Brain CancersNews
A new study explains why a particular mutation in the epidermal growth factor receptor (EGFR) results in more aggressive tumors and poorer overall survival of patients diagnosed with the brain cancer glioblastoma multiforme (GBM).READ MORE